4H-Chromene-based anticancer agents towards multi-drug resistant HL60/MX2 human leukemia: SAR at the 4th and 6th positions.

about

Design, synthesis and fluorescence property evaluation of blue emitting triazole-linked chromene peptidomimetics.Exploring the Structure-Activity Relationship and Mechanism of a Chromene Scaffold (CXL Series) for Its Selective Antiproliferative Activity toward Multidrug-Resistant Cancer Cells

P2860

Q50176114-B522B7C6-EF77-4DF4-9571-8EB3231D6683 Q57170103-B9A25B2F-2B87-4360-88BA-755E9B730850

P2860

4H-Chromene-based anticancer agents towards multi-drug resistant HL60/MX2 human leukemia: SAR at the 4th and 6th positions.

Item

http://www.wikidata.org/entity/Q38909364

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

4H-Chromene-based anticancer a ...... at the 4th and 6th positions.

@en

type

Item

label

4H-Chromene-based anticancer a ...... at the 4th and 6th positions.

@en

prefLabel

4H-Chromene-based anticancer a ...... at the 4th and 6th positions.

@en

P1476

4H-Chromene-based anticancer a ...... at the 4th and 6th positions.

@en

P2093

Bo Zhou

http://www.w3.org/2001/XMLSchema#string

Chengguo Xing

http://www.w3.org/2001/XMLSchema#string

Denise Casemore

http://www.w3.org/2001/XMLSchema#string

Gopalakrishnan Aridoss

http://www.w3.org/2001/XMLSchema#string

Manohar Puppala

http://www.w3.org/2001/XMLSchema#string

Sreekanth Narayanapillai

http://www.w3.org/2001/XMLSchema#string

Xinghua Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Durability of Kinase-Directed Therapies--A Network Perspective on Response and Resistance

Cancer statistics, 2012

Cancer statistics, 2013

Ethyl 2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017): a novel scaffold that resensitizes multidrug resistant leukemia cells to chemotherapy

Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancer.

Resistance to chemotherapy in cancer: a complex and integrated cellular response.

An overview of cancer multidrug resistance: a still unsolved problem.

A novel SERCA inhibitor demonstrates synergy with classic SERCA inhibitors and targets multidrug-resistant AML.

Structure-activity relationship (SAR) study of ethyl 2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017) and the potential of the lead against multidrug resistance in cancer treatment.

Structure-activity relationship and molecular mechanisms of ethyl 2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017) and its analogues.

P304

1292-1297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BMC.2016.01.056

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26867486

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

6131690

http://www.w3.org/2001/XMLSchema#string

4H-Chromene-based anticancer agents towards multi-drug resistant HL60/MX2 human leukemia: SAR at the 4th and 6th positions.

about

P2860

P2860

4H-Chromene-based anticancer agents towards multi-drug resistant HL60/MX2 human leukemia: SAR at the 4th and 6th positions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932